Objective Tumor Response of Hepatocellular Carcinoma Obtained by Transarterial Radioembolization with Iodine-131-Lipiodol Versus Transarterial Chemoembolization for Patients with and without Portal Venous Thrombosis: A Controlled Interventional Trial

• Published in: Academic radiology Vol. 31; no. 5; p. 1839
• Main Authors: Oliveira Ribeiro, Michele Costa de, Moda, Kerolyn Adorne, Alvarez, Matheus, Koga, Katia Hiromoto, Moriguchi, Sônia Marta, Carvalho, Fábio Cardoso, Pinheiro, Rafael Soares Nunes, Qi, Xingshun, Romeiro, Fernando Gomes
• Format: Journal Article
• Language: English
• Published: United States 01.05.2024
• Subjects: Aged; Carcinoma, Hepatocellular - therapy; Chemoembolization, Therapeutic - methods; Ethiodized Oil - administration & dosage; Female; Humans; Iodine Radioisotopes - therapeutic use; Liver Neoplasms - therapy; Male; Middle Aged; Portal Vein; Prospective Studies; Radiopharmaceuticals - therapeutic use; Treatment Outcome; Venous Thrombosis - diagnostic imaging; Venous Thrombosis - therapy; Hepatocellular carcinoma; Objective tumor response; Transarterial chemoembolization; Transarterial radioembolization; Portal vein thrombosis

Hepatocellular carcinoma (HCC) treatment often requires transarterial chemoembolization (TACE). However, TACE efficacy is controversial in the presence of portal vein thrombosis (PVT). Although transarterial radioembolization (TARE) benefit was previously documented in PVT, neither the objective tum...